Recent progress in targeting the sialylated glycan-SIGLEC axis in cancer immunotherapy

Malignant tumors are complex structures composed of cancer cells and tumor microenvironmental cells. In this complex structure, cells cross-talk and interact, thus jointly promoting cancer development and metastasis. Recently, immunoregulatory molecule-based cancer immunotherapy has greatly improved...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Yingyan, Peng, Wenjie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Compuscript 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10246440/
https://www.ncbi.nlm.nih.gov/pubmed/37133224
http://dx.doi.org/10.20892/j.issn.2095-3941.2023.0046

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10246440/
https://www.ncbi.nlm.nih.gov/pubmed/37133224
http://dx.doi.org/10.20892/j.issn.2095-3941.2023.0046

Ejemplares similares